AAAAAA

   
Results: 1-9 |
Results: 9
INSULIN-RESISTANCE IN ESSENTIAL-HYPERTENSION IS RELATED TO PLASMA-RENIN ACTIVITY
Authors: LIND L RENELAND R ANDERSSON PE HAENNI A LITHELL H
Citation: L. Lind et al., INSULIN-RESISTANCE IN ESSENTIAL-HYPERTENSION IS RELATED TO PLASMA-RENIN ACTIVITY, Journal of human hypertension, 12(6), 1998, pp. 379-382
INSULIN SENSITIVITY CHANGES AFTER ATENOLOL TREATMENT DEPEND ON INITIAL INSULIN SENSITIVITY AND THE ALTERATION IN BODY-MASS INDEX
Authors: HAENNI A NILSSON P POLLARE T ANDERSSON PE RENELAND R LITHELL H
Citation: A. Haenni et al., INSULIN SENSITIVITY CHANGES AFTER ATENOLOL TREATMENT DEPEND ON INITIAL INSULIN SENSITIVITY AND THE ALTERATION IN BODY-MASS INDEX, Journal of hypertension, 16, 1998, pp. 31047-31047
ATHEROGENIC LIPID FRACTIONS ARE RELATED TO IONIZED MAGNESIUM STATUS
Authors: HAENNI A OHRVALL M LITHELL H
Citation: A. Haenni et al., ATHEROGENIC LIPID FRACTIONS ARE RELATED TO IONIZED MAGNESIUM STATUS, The American journal of clinical nutrition, 67(2), 1998, pp. 202-207
THE ALTERATIONS IN INSULIN SENSITIVITY DURING ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR TREATMENT ARE RELATED TO CHANGES IN THE CALCIUM MAGNESIUM BALANCE/
Authors: HAENNI A BERGLUND L RENELAND R ANDERSSON PE LIND L LITHELL H
Citation: A. Haenni et al., THE ALTERATIONS IN INSULIN SENSITIVITY DURING ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR TREATMENT ARE RELATED TO CHANGES IN THE CALCIUM MAGNESIUM BALANCE/, American journal of hypertension, 10(2), 1997, pp. 145-151
THE BLOOD-PRESSURE RESPONSE TO ANTIHYPERTENSIVE TREATMENT WITH LISINOPRIL OR BENDROFLUAZIDE IS RELATED TO THE CALCIUM AND MAGNESIUM CONTENTS IN SKELETAL-MUSCLE
Authors: HAENNI A LIND L LITHELL H
Citation: A. Haenni et al., THE BLOOD-PRESSURE RESPONSE TO ANTIHYPERTENSIVE TREATMENT WITH LISINOPRIL OR BENDROFLUAZIDE IS RELATED TO THE CALCIUM AND MAGNESIUM CONTENTS IN SKELETAL-MUSCLE, American journal of hypertension, 9(3), 1996, pp. 273-276
URAPIDIL TREATMENT DECREASES PLASMA-FIBRINOGEN CONCENTRATION IN ESSENTIAL-HYPERTENSION
Authors: HAENNI A LITHELL H
Citation: A. Haenni et H. Lithell, URAPIDIL TREATMENT DECREASES PLASMA-FIBRINOGEN CONCENTRATION IN ESSENTIAL-HYPERTENSION, Metabolism, clinical and experimental, 45(10), 1996, pp. 1221-1229
ELECTROLYTE CHANGES AND METABOLIC EFFECTS OF LISINOPRIL BENDROFLUAZIDE TREATMENT - RESULTS FROM A RANDOMIZED, DOUBLE-BLIND-STUDY WITH PARALLEL GROUPS/
Authors: HAENNI A ANDERSSON PE LIND L BERNE C LITHELL H
Citation: A. Haenni et al., ELECTROLYTE CHANGES AND METABOLIC EFFECTS OF LISINOPRIL BENDROFLUAZIDE TREATMENT - RESULTS FROM A RANDOMIZED, DOUBLE-BLIND-STUDY WITH PARALLEL GROUPS/, American journal of hypertension, 7(7), 1994, pp. 615-622
METABOLIC EFFECTS OF LONG-TERM ANGIOTENSIN-CONVERTING ENZYME-INHIBITION WITH FOSINOPRIL IN PATIENTS WITH ESSENTIAL-HYPERTENSION - RELATIONSHIP TO ANGIOTENSIN-CONVERTING ENZYME-INHIBITION
Authors: RENELAND R ANDERSSON PE HAENNI A LITHELL H
Citation: R. Reneland et al., METABOLIC EFFECTS OF LONG-TERM ANGIOTENSIN-CONVERTING ENZYME-INHIBITION WITH FOSINOPRIL IN PATIENTS WITH ESSENTIAL-HYPERTENSION - RELATIONSHIP TO ANGIOTENSIN-CONVERTING ENZYME-INHIBITION, European Journal of Clinical Pharmacology, 46(5), 1994, pp. 431-436
TREATMENT WITH A BETA-BLOCKER WITH BETA(2)-AGONISM IMPROVES GLUCOSE AND LIPID-METABOLISM IN ESSENTIAL-HYPERTENSION
Authors: HAENNI A LITHELL H
Citation: A. Haenni et H. Lithell, TREATMENT WITH A BETA-BLOCKER WITH BETA(2)-AGONISM IMPROVES GLUCOSE AND LIPID-METABOLISM IN ESSENTIAL-HYPERTENSION, Metabolism, clinical and experimental, 43(4), 1994, pp. 455-461
Risultati: 1-9 |